Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
The transition to include in vitro-based data in chemical hazard assessment has resulted in the development and implementation of screening assays to cover a diversity of biological pathways, including recently added assays to interrogate chemical disruption of proteins relevant to thyroid signaling pathways. Iodotyrosine deiodinase (IYD), the iodide recycling enzyme, is one such thyroid-relevant endpoint for which a human-based screening assay has recently been developed and used to screen large libraries of chemicals. Presented here is the development of an amphibian IYD inhibition assay and its implementation to conduct a cross-species comparison between chemical inhibition of mammalian and non-mammalian IYD enzyme activity. The successful development of an amphibian IYD inhibition assay was based on demonstration of sufficient IYD enzyme activity in several tissues collected from larval Xenopus laevis. With this new assay, 154 chemicals were tested in concentration-response to provide a basis for comparison of relative chemical potency to results obtained from the human IYD assay. Most chemicals exhibited similar inhibition in both assays, with less than 25% variation in median inhibition for 120 of 154 chemicals and 85% concordance in categorization of "active" (potential IYD inhibitor) versus "inactive". For chemicals that produced 50% or greater inhibition in both assays, rank-order potency was similar, with the majority of the IC50s varying by less than 2-fold (and all within an order of magnitude). Most differences resulted from greater maximum inhibition or higher chemical potency observed with human IYD. This strong cross-species agreement suggests that results from the human-based assay would be conservatively predictive of chemical effects on amphibian IYD.
Ankley,
Evaluation of the scientific underpinnings for identifying estrogenic chemicals in nonmammalian taxa using mammalian test systems.
2016, Pubmed
Ankley,
Evaluation of the scientific underpinnings for identifying estrogenic chemicals in nonmammalian taxa using mammalian test systems.
2016,
Pubmed
Asnake,
Species differences in ligand interaction and activation of estrogen receptors in fish and human.
2019,
Pubmed
Brix,
Molecules important for thyroid hormone synthesis and action - known facts and future perspectives.
2011,
Pubmed
Committee on Human and Environmental Exposure Science in the 21st Century,
2012,
Pubmed
Dang,
Comparison of chemical-induced transcriptional activation of fish and human estrogen receptors: regulatory implications.
2011,
Pubmed
Dong,
Application of a nonradioactive assay for high throughput screening for inhibition of thyroid hormone uptake via the transmembrane transporter MCT8.
2017,
Pubmed
Dong,
A rapid assay of human thyroid peroxidase activity.
2020,
Pubmed
Filer,
tcpl: the ToxCast pipeline for high-throughput screening data.
2017,
Pubmed
Fujimoto,
Direct activation of Xenopus iodotyrosine deiodinase by thyroid hormone receptor in the remodeling intestine during amphibian metamorphosis.
2012,
Pubmed
,
Xenbase
Gaupale,
Localization and enzyme activity of iodotyrosine dehalogenase 1 during metamorphosis of frog Microhyla ornata.
2009,
Pubmed
Gnidehou,
Cloning and characterization of a novel isoform of iodotyrosine dehalogenase 1 (DEHAL1) DEHAL1C from human thyroid: comparisons with DEHAL1 and DEHAL1B.
2006,
Pubmed
Goswami,
Studies on a soluble thyroid iodotyrosine deiodinase: activation by NADPH and electron carriers.
1977,
Pubmed
Green,
Inhibition of thyroidal iodotyrosine deiodination by tyrosine analogues.
1968,
Pubmed
Green,
Effects of 3-nitro-L-tyrosine on thyroid function in the rat: an experimental model for the dehalogenase defect.
1971,
Pubmed
Grulke,
EPA's DSSTox database: History of development of a curated chemistry resource supporting computational toxicology research.
2019,
Pubmed
Hallinger,
Development of a screening approach to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS).
2017,
Pubmed
Hornung,
Screening the ToxCast Phase 1 Chemical Library for Inhibition of Deiodinase Type 1 Activity.
2018,
Pubmed
Houck,
Evaluation of a multiplexed, multispecies nuclear receptor assay for chemical hazard assessment.
2021,
Pubmed
,
Xenbase
Jayarama-Naidu,
A Nonradioactive Uptake Assay for Rapid Analysis of Thyroid Hormone Transporter Function.
2015,
Pubmed
Kavlock,
Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management.
2012,
Pubmed
Krewski,
A framework for the next generation of risk science.
2014,
Pubmed
Krewski,
Toxicity testing in the 21st century: progress in the past decade and future perspectives.
2020,
Pubmed
Lecat-Guillet,
A 96-well automated radioiodide uptake assay for sodium/iodide symporter inhibitors.
2007,
Pubmed
Mayasich,
Xenopus laevis and human type 3 iodothyronine deiodinase enzyme cross-species sensitivity to inhibition by ToxCast chemicals.
2021,
Pubmed
,
Xenbase
Medvedev,
Harmonized Cross-Species Assessment of Endocrine and Metabolic Disruptors by Ecotox FACTORIAL Assay.
2020,
Pubmed
Meinhold,
Effects of iodotyrosine deiodinase inhibition on serum concentrations and turnover of diiodotyrosine (DIT) and thyroxine (T4) in the rat.
1983,
Pubmed
Montaño,
New approaches to assess the transthyretin binding capacity of bioactivated thyroid hormone disruptors.
2012,
Pubmed
Moreno,
Genetics and phenomics of hypothyroidism and goiter due to iodotyrosine deiodinase (DEHAL1) gene mutations.
2010,
Pubmed
Murk,
Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals.
2013,
Pubmed
National Academies of Sciences, Engineering, and Medicine,
2017,
Pubmed
Noyes,
Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches.
2019,
Pubmed
Oktay,
129I and 127I transport in the Mississippi River.
2001,
Pubmed
Olker,
Evaluating Iodide Recycling Inhibition as a Novel Molecular Initiating Event for Thyroid Axis Disruption in Amphibians.
2018,
Pubmed
,
Xenbase
Olker,
Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases.
2019,
Pubmed
Olker,
In vitro screening for chemical inhibition of the iodide recycling enzyme, iodotyrosine deiodinase.
2021,
Pubmed
Paul,
Cross-species analysis of thyroperoxidase inhibition by xenobiotics demonstrates conservation of response between pig and rat.
2013,
Pubmed
Paul,
Development of a thyroperoxidase inhibition assay for high-throughput screening.
2014,
Pubmed
Paul Friedman,
Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors Within the ToxCast Phase I and II Chemical Libraries.
2016,
Pubmed
Phatarphekar,
Iodotyrosine deiodinase: a unique flavoprotein present in organisms of diverse phyla.
2014,
Pubmed
Renko,
A Nonradioactive DEHAL Assay for Testing Substrates, Inhibitors, and Monitoring Endogenous Activity.
2016,
Pubmed
Renko,
Identification of iopanoic acid as substrate of type 1 deiodinase by a novel nonradioactive iodide-release assay.
2012,
Pubmed
Renko,
An Improved Nonradioactive Screening Method Identifies Genistein and Xanthohumol as Potent Inhibitors of Iodothyronine Deiodinases.
2015,
Pubmed
Ritz,
Dose-Response Analysis Using R.
2015,
Pubmed
Rokita,
Efficient use and recycling of the micronutrient iodide in mammals.
2010,
Pubmed
Rosenberg,
Iodotyrosine deiodinase from bovine thyroid.
1984,
Pubmed
Shimizu,
Structure-activity relationships of 44 halogenated compounds for iodotyrosine deiodinase-inhibitory activity.
2013,
Pubmed
Solís-S,
Comparative kinetic characterization of rat thyroid iodotyrosine dehalogenase and iodothyronine deiodinase type 1.
2004,
Pubmed
Sun,
Expression of Iodotyrosine Deiodinase in Thyroid and Other Organs in Iodine-Deficient and Iodine-Excess Rats.
2015,
Pubmed
Thomas,
The Next Generation Blueprint of Computational Toxicology at the U.S. Environmental Protection Agency.
2019,
Pubmed
Villeneuve,
High-throughput screening and environmental risk assessment: State of the science and emerging applications.
2019,
Pubmed
Zhang,
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.
1999,
Pubmed
Zhang,
Interspecies Variation between Fish and Human Transthyretins in Their Binding of Thyroid-Disrupting Chemicals.
2018,
Pubmed
Zoeller,
General background on the hypothalamic-pituitary-thyroid (HPT) axis.
2007,
Pubmed
